BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23642520)

  • 1. Re. 'Re. 'Cost-effectiveness of vascular access for haemodialyis: arteriovenous fistulas versus arteriovenous grafts".
    Tordoir JH
    Eur J Vasc Endovasc Surg; 2013 Jul; 46(1):150-1. PubMed ID: 23642520
    [No Abstract]   [Full Text] [Related]  

  • 2. Re. ‘Cost-effectiveness of vascular access for haemodialyis: arteriovenous fistulas versus arteriovenous grafts’.
    McDermott M; Aitken E; Geddes C; Clancy M
    Eur J Vasc Endovasc Surg; 2013 Jul; 46(1):149-50. PubMed ID: 23642522
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of vascular access for haemodialysis: arteriovenous fistulas versus arteriovenous grafts.
    Leermakers JJ; Bode AS; Vaidya A; van der Sande FM; Evers SM; Tordoir JH
    Eur J Vasc Endovasc Surg; 2013 Jan; 45(1):84-92. PubMed ID: 23153926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why "fistula first" matters: increased durability, less interventions, and decreased costs.
    Bazan HA
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):22. PubMed ID: 20020432
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of Early Cannulation Grafts on Quality and Cost of Care for Patients With End-Stage Renal Disease.
    Desai SS
    Ann Vasc Surg; 2019 Oct; 60():203-210. PubMed ID: 31200049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodialysis access creation episode-based cost measure.
    Shireman PK; Woo K; Lipsitz EC
    J Vasc Surg; 2019 Apr; 69(4):1322. PubMed ID: 30905368
    [No Abstract]   [Full Text] [Related]  

  • 7. Choice of Hemodialysis Access in Older Adults: A Cost-Effectiveness Analysis.
    Hall RK; Myers ER; Rosas SE; O'Hare AM; Colón-Emeric CS
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):947-954. PubMed ID: 28522655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of immediate access arteriovenous grafts versus standard grafts for hemodialysis.
    Mohapatra A; Yuo TH; Lowenkamp MN; Wagner JK; Dillavou ED; Chaer RA; Avgerinos ED
    J Vasc Surg; 2021 Feb; 73(2):581-587. PubMed ID: 32473345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic analysis of angiography and preemptive angioplasty to prevent hemodialysis-access thrombosis.
    Bittl JA; Cohen DJ; Seek MM; Feldman RL
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):14-21. PubMed ID: 19862805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Field testing and refining the hemodialysis access creation episode-based cost measure.
    Shireman PK; Woo K; Lipsitz EC
    J Vasc Surg; 2019 May; 69(5):1643. PubMed ID: 31010526
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantifying The Costs of Creating and Maintaining Hemodialysis Access in An All-Payer Rate-Controlled Health System.
    Sorber R; Canner JK; Abularrage CJ; Shireman PK; Segev DL; Black Iii JH; Woo K; Hicks CW
    Ann Vasc Surg; 2021 Oct; 76():142-151. PubMed ID: 34153489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of dialysis and vascular access in Taiwan.
    Chen CF; Chen FA; Lee TL; Liao LF; Chen CY; Tan AC; Chan CH; Lin CC
    J Vasc Access; 2019 Jul; 20(4):368-373. PubMed ID: 30354908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodialysis vascular access: current practices amongst Indian nephrologists.
    Bansal D; Kher V; Gupta KL; Banerjee D; Jha V
    J Vasc Access; 2018 Mar; 19(2):172-176. PubMed ID: 29192721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database.
    Lee HS; Ju YS; Song YR; Kim JK; Choi SR; Joo N; Kim HJ; Park P; Kim SG
    Korean J Intern Med; 2018 Nov; 33(6):1160-1168. PubMed ID: 30396254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular versus surgical creation of arteriovenous fistula in hemodialysis patients: Cost-effectiveness and budget impact analyses.
    Rognoni C; Tozzi M; Tarricone R
    J Vasc Access; 2021 Jan; 22(1):48-57. PubMed ID: 32425096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bypass grafts for hemoaccess.
    Tellis VA
    J Am Coll Surg; 1998 Nov; 187(5):569. PubMed ID: 9809577
    [No Abstract]   [Full Text] [Related]  

  • 17. The economic issue of vascular access within the Japanese medical reimbursement system.
    Takemoto Y; Naganuma T
    J Vasc Access; 2015 Nov; 16 Suppl 10():S9-12. PubMed ID: 26349862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are early cannulation arteriovenous grafts (ecAVG) a viable alternative to tunnelled central venous catheters (TCVCs)? An observational "virtual study" and budget impact analysis.
    Aitken E; Iqbal K; Thomson P; Kasthuri R; Kingsmore D
    J Vasc Access; 2016 May; 17(3):220-8. PubMed ID: 27032450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis Vascular Access: Rising Costs as a Surrogate Marker for Patency and Function of Arteriovenous Fistulas.
    Feldman ZM; Liu LB; Abramowitz SD; Faries PL; Marin ML; Schanzer HR; Teodorescu VJ
    Ann Vasc Surg; 2017 Jan; 38():136-143. PubMed ID: 27546853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of the use of stent grafts to salvage failed arteriovenous accesses.
    Webb KM; Cull DL; Carsten CG; Johnson BL; Taylor SM
    Ann Vasc Surg; 2010 Jan; 24(1):34-8. PubMed ID: 19765947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.